# iDAP Injection in the Treatment of Parkinson's Disease

> **NCT06583291** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Anhui Provincial Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Allogeneic dopaminergic neural precursor cell(iDAP)

## Key facts

- **NCT ID:** NCT06583291
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2028-10-01
- **Final completion:** 2028-10-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2024-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06583291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06583291, "iDAP Injection in the Treatment of Parkinson's Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06583291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*